BofA Securities has recently reduced Esperion Therapeutics Inc (ESPR) stock to Underperform rating, as announced on June 20, 2024, according to Finviz. Earlier, on January 3, 2024, BofA Securities had ...

BofA raised the firm’s price target on Spotify (SPOT) to $515 from $430 and keeps a Buy rating on the shares after the company reported a ...

Warren Buffett has grown Berkshire Hathaway's cash pile to more than $300 billion — a record high. The famed investor has ...

U.S. stocks turned mostly higher Wednesday after investors were handed an October retail inflation report that supported ...